Researchers at Johns Hopkins are developing AI-driven video analysis tools to provide surgeons with unbiased skill assessments and personalized feedback. The system segments surgical procedures, detects instruments, and assesses skill in cataract surgery. Dr. Shameema Sikder is leading the development of technologies to improve ophthalmic surgical care standards internationally. Why it matters: AI-based surgical skill assessment could standardize training and improve patient outcomes in the region and globally.
This paper introduces a method for automatically designing convolutional neural network (CNN) architectures tailored for diabetic retinopathy (DR) diagnosis using fundus images. The approach uses k-medoid clustering, PCA, and inter/intra-class variations to optimize CNN depth and width. Validated on datasets including a local Saudi dataset and Kaggle benchmarks, the custom-designed models outperform pre-trained CNNs with fewer parameters.
Researchers from MBZUAI introduced RP-SAM2, a method to improve surgical instrument segmentation by refining point prompts for more stable results. RP-SAM2 uses a novel shift block and compound loss function to reduce sensitivity to point prompt placement, improving segmentation accuracy in data-constrained settings. Experiments on the Cataract1k and CaDIS datasets show that RP-SAM2 enhances segmentation accuracy and reduces variance compared to SAM2, with code available on GitHub.
Sir Michael Brady, professor at Oxford and MBZUAI, argues that AI in healthcare must move beyond pattern recognition to causal understanding. He states that clinicians require AI models to articulate their reasoning behind diagnoses and therapy recommendations, not just provide statistical scores. He believes AI's immediate impact will be in personalized medicine, tailoring treatments to the individual rather than relying on epidemiological averages. Why it matters: This perspective highlights the critical need for explainable AI in sensitive domains like healthcare, paving the way for more trustworthy and clinically relevant AI applications in the region.
Dr. Andrew Bastawrous, CEO/co-founder of Peek, discussed his work on mobile eye clinics at KAUST. He developed Peek Acuity and Peek Retina, which turn smartphones into tools for detecting visual impairment. The technology uses smartphone screens and camera clip-ons to image inside the eye. Why it matters: This low-cost mobile ophthalmic tool has the potential to prevent and treat vision loss in underserved communities.